Input Stories

Report: Hospitals Make Big Profits on 340B Program

Hospitals and clinics are making big money off an initiative created by Congress to help expand affordable medication access to low-income patients, according to a new report (Bloomberg Government, subscription).

What’s going on: “Hospitals pocketed $142.2 billion in 2025 from the 340B drug discount program, more than doubling their profits [from the program] over four years,” a report done by consulting firm BRG on behalf of PhRMA, the trade group representing pharmaceutical companies.

  • “The Size of the 340B Program,” released this month, “found [that] hospitals retained high revenues from 340B based on the difference between the price they paid for a discounted drug and the amount they were reimbursed.”

The NAM’s view: The NAM has long advocated for reform of 340B and the return to the program’s original intent.

  • “As the second largest federal health care program, 340B has massively expanded beyond its original purpose—and many hospitals have exploited the program to increase profits,” the NAM wrote in its 2026 health care roadmap, “Prescription for a Healthy Workforce.”
  • “This abuse has increased the cost of employer-sponsored insurance by tens of billions of dollars and contributed to ever-increasing health care costs for manufacturers and their employees.”

Why action must be taken: The program’s expansion is contributing to skyrocketing employer health care costs.

  • The growth of 340B was associated with about $23 billion in additional employer-based health care expenses in 2023 and costs employees approximately $4.5 billion annually in added insurance premiums, the NAM told the Department of Health and Human Services in April.

The bottom line: “Manufacturers believe the 340B program is an important tool in expanding care for underserved communities and urge fundamental changes that would restore this program to its core purpose,” the NAM advocated to HHS.

  • “Abuse of the program in the name of hospital profits has hurt manufacturers and their employees, contributing to the ever-increasing costs of health care for the industry.”